1-4 of 4
Jie Sun, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Maintenance Sorafenib Is Superior to Prophylactic DLI in Improving the Prognosis of FLT3-ITD-Positive AML after Allogeneic HSCT

Jimin Shi, MD, Liqin Cao, MD, Yi Luo, MD, Yanmin Zhao, MD, Yamin Tan, MD, Jian Yu, MD, Xiaoyu Lai, MD, Yuanyuan Zhu, MD, Yongxian Hu, MD, Jingsong He, MD, Jie Sun, MD, Weiyan Zheng, MD, Guoqing Wei, MD, He Huang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2668.
https://doi.org/10.1182/blood-2019-127594
Published: 2019
Journal Articles

Superior Therapeutic Efficacy of Chimeric Antigen Receptor Modified T Cells Against CD19 over Chemotherapy in Relapsed/Refractory Acute Lymphocytic Leukemia

Yongxian Hu, Jian Yu, Yi Luo, Jimin Shi, Zhao Wu, PhD, Guoqing Wei, MD PhD, Jie Sun, MD PhD, Zhen Cai, Lei Xiao, He Huang, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3978.
https://doi.org/10.1182/blood.V128.22.3978.3978
Published: 2016
Journal Articles

Chemotherapy Combined with Granulocyte Colony Stimulating Factor (G-CSF) for Mobilization of CD34 + Cells in Lymphoma and Multiple Myeloma Patients

Gaofeng Zheng, MD, Yanlong Zheng, MD, Yi Luo, Jimin Shi, Weiyan Zheng, Guoqing Wei, Jie Sun, MD PhD, He Huang, MD PhD, Zhen Cai, MD PhD, Jingsong He, PhD
Journal: Blood
Blood (2015) 126 (23): 5441.
https://doi.org/10.1182/blood.V126.23.5441.5441
Published: 2015
Journal Articles

Efficacy and Safety of Bortezomib Based Regimens Retreatment in Relapsed Multiple Myeloma Patients: Results from a Retrospective Study.

Wenjun Wu, MD, Gaofeng Zheng, MD, Xiaoyan Han, MD, Yi Zhao, PhD, Donghua He, PhD, Yang Yang, PhD, Jingsong He, PhD, Weiyan Zheng, Jie Sun, MD PhD, Jimin Shi, Guoqing Wei, MD PhD, He Huang, MD PhD, Zhen Cai
Journal: Blood
Blood (2015) 126 (23): 5387.
https://doi.org/10.1182/blood.V126.23.5387.5387
Published: 2015